Roundtable Discussion: Enhancing Clinical Trial Design to Effectively Catalyse Clinical Studies & Accelerate IBD Drug Development
Time: 1:30 pm
day: AI/Machine Learning Pre-Conference Focus Day
- How can utilise AI to improve patient selection and eligibility screening for novel therapeutics?
- How can we use the wealth of clinical data for protocol optimization within the context of clinical design?
- Can we use AI/ML for predictive analytics, identifying potential complications or negative reactions in early stages of clinical trials?
- Could we implement real-time patient monitoring to identify trends or anomalies that may require immediate attention?
- Are modalities required for companion diagnostics sufficient to implement into clinical trials?